Skip to main content
Premium Trial:

Request an Annual Quote

Gulf Coast Chemical Genomics Consortium to Use Invitrogen siRNA Screening Tech for Disease Studies

NEW YORK (GenomeWeb News) - A consortium of Texas research institutions studying genomics and disease will use Invitrogen’s siRNA library and screening tools to study cancer, diabetes, and metabolic disorders, the company said today.
 
Researchers at six locations, including the University of Texas at Houston and at Galveston, Baylor College, M.D. Anderson Cancer Center, and Rice University, will use Invitrogen’s human kinase and human and mouse nuclear receptor collections in high-throughput image-based screening and gene expression experimental research.
 
The consortium, known as the Gulf Coast Consortium for Chemical Genomics, will use Invitrogen’s SYBR GreenER qPCR technology, and its Molecular Probes image tools to measure various effects on siRNA molecules.
 
Financial terms of the agreement were not released.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.